Ameritas Investment Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-9,579
Closed -$1.66M – 1253
2015
Q1
$1.66M Buy
9,579
+154
+2% +$22.6K 0.11% 211
2014
Q4
$1.08M Hold
9,425
– – 0.07% 268
2014
Q3
$1.47M Sell
9,425
-18
-0.2% -$2.61K 0.11% 215
2014
Q2
$1.17M Sell
9,443
-222
-2% -$24.5K 0.08% 256
2014
Q1
$1M Sell
9,665
-243
-2% -$24.9K 0.08% 287
2013
Q4
$891K Buy
9,908
+133
+1% +$10.6K 0.07% 329
2013
Q3
$654K Buy
+9,775
New +$674K 0.06% 399

Other funds holding SLXP

Ameritas Investment Partners's SLXP Position: Q2 2015 in Review

Ameritas Investment Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 9,579 shares — an estimated $1.66M sold.

Ameritas Investment Partners first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $1.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Ameritas Investment Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Ameritas Investment Partners sold 9,579 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.66M.
  • Ameritas Investment Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
  • Ameritas Investment Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.66M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Ameritas Investment Partners's 13F filing for Q2 2015, filed 7 Aug 2015.